GlaxoSmithKline S.A.E (EGX: BIOC)

GlaxoSmithKline S.A.E Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	175.3	829.34	585.85	73.57	22.16	251.21
Cash & Short-Term Investments	175.3	829.34	585.85	73.57	22.16	251.21
Cash Growth	83.69%	41.56%	696.36%	232.01%	-91.18%	-18.04%
Accounts Receivable	518.11	685.96	424.68	253.94	269.39	234.41
Other Receivables	76.94	23.89	318.64	408.81	221.5	492.69
Receivables	1,474	1,176	1,165	830.42	641.44	817.25
Inventory	1,226	695.27	485.89	500.45	456.05	342.62
Prepaid Expenses	-	-	-	17.58	20.46	43.96
Other Current Assets	162.13	164.7	216.65	126.47	143.34	99.96
Total Current Assets	3,037	2,866	2,454	1,548	1,283	1,555
Property, Plant & Equipment	594.5	572.14	548.11	540.21	476.53	451.27
Long-Term Investments	-	6.34	24.45	12.3	21.51	41
Goodwill	-	-	137.65	238.65	238.65	238.65
Long-Term Deferred Tax Assets	-	17.43	-	-	-	47.42
Other Long-Term Assets	112.62	96.48	21.33	85.09	97.2	52.81
Total Assets	3,745	3,558	3,185	2,425	2,117	2,386
Accounts Payable	197.23	424.53	176.8	104.54	49.28	68.39
Accrued Expenses	560.39	524.12	304.51	581.22	522.35	461.89
Short-Term Debt	19.24	-	-	118.21	145.73	235.16
Current Portion of Leases	32.92	28.39	17.48	29.52	-	-
Current Income Taxes Payable	10.48	97.93	308.57	17.38	1.23	41.89
Other Current Liabilities	913.19	448.98	585.89	161.22	170.56	169.37
Total Current Liabilities	1,733	1,524	1,393	1,012	889.15	976.71
Long-Term Leases	79.82	68.63	52.07	32.24	-	-
Long-Term Deferred Tax Liabilities	17.21	-	11.31	22.46	15.09	-
Total Liabilities	1,830	1,593	1,457	1,067	904.25	1,169
Common Stock	835.14	835.14	835.14	835.14	835.14	835.14
Retained Earnings	1,078	1,130	892.71	522.24	377.36	381.17
Total Common Equity	1,914	1,965	1,728	1,357	1,213	1,216
Minority Interest	0.6	0.6	0.58	0.58	0.59	0.57
Shareholders' Equity	1,914	1,965	1,728	1,358	1,213	1,217
Total Liabilities & Equity	3,745	3,558	3,185	2,425	2,117	2,386
Total Debt	131.98	97.03	69.55	179.97	145.73	235.16
Net Cash (Debt)	43.33	732.32	516.3	-106.41	-123.58	16.05
Net Cash Growth	81.83%	41.84%	-	-	-	-94.77%
Net Cash Per Share	0.52	8.77	6.18	-1.27	-1.48	0.19
Filing Date Shares Outstanding	83.51	83.51	83.51	83.51	83.51	83.51
Total Common Shares Outstanding	83.51	83.51	83.51	83.51	83.51	83.51
Working Capital	1,304	1,342	1,060	536.41	394.3	578.29
Book Value Per Share	22.91	23.53	20.69	16.25	14.52	14.56
Tangible Book Value	1,914	1,965	1,590	1,119	973.85	977.66
Tangible Book Value Per Share	22.91	23.53	19.04	13.40	11.66	11.71
Land	17.59	17.59	12.65	12.65	12.65	12.65
Buildings	83.47	83.47	97.81	97.81	97.81	97.81
Machinery	702.48	668.83	662.18	629.59	571.91	352.87
Construction In Progress	118.9	108.51	88.86	98.67	122.98	298.17
Leasehold Improvements	26.81	26.81	26.85	42.34	42.34	32.88

Source: S&P Capital IQ. Standard template. Financial Sources.